It is used to treat:

• Non-small cell lung cancer
• Breast cancer
• Stomach or gastric cancer
• Prostate cancer
• Head and neck cancer

Docet 120mg Injection works by inhibiting the microtubule structures present in the cell. Microtubule structures help cancer cells to divide and multiply, which slows the growth of cancer cells and eventually kills them.

Inform your doctor about any prescribed medications, over-the-counter medications, nutritional or vitamin supplements, and herbal products that you are taking or have taken before the treatment. Certain medications tend to interact with Docet 120mg Injection and can cause potential side effects. 

• Keep Docet 120mg Injection out of sight and reach of children.
• Do not store above 25°C.

Docet 120mg Injection will be given by infusion into one of your veins (intravenous use). It is administered by a healthcare professional. The dose of this Injection depends on your weight and general condition. Do not self-administer. 

Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them. 

Serious:

• Severe allergic reactions
• Severe fluid retention
• Severe skin problems
• Swelling of the small intestine and colon

Common:

• Headache, dizziness
• Fever, infections
• Low blood cell count
• Loss of appetite
• Trouble sleeping
• Joint or muscle pain
• Alteration in the sense of taste
• Eye problems, bleeding from the nose
• Nausea, vomiting
• Diarrhea, constipation
• Abdominal pain
• Hair loss, change in color of your nails
• Change or absence of menstrual period
• Weight loss
• Tiredness
• Dry mouth
• High blood sugar
• Decreased blood pressure, rapid heartbeat

It is advised to use effective birth control for men and women taking Docet 120mg Injection. Women of reproductive potential must use effective contraception during and after six months of therapy. Male patients receiving this Injection treatment should refrain from fathering children and use reliable contraception for six months following the treatment. Inform your healthcare provider if you experience the symptoms of intestinal problems, including stomach pain, tenderness, or diarrhea. Your doctor may suggest regular blood tests to monitor your blood cells and liver function during treatment with this medicine.

1. Goodman & Gilman’s, The Pharmacological Basis of Therapeutics, Cytotoxic agents, 12th edition, 2011, 1707 - 1709.
2. KD Tripathi, Essentials of Medical Pharmacology, Anticancer drugs, 7th edition, 2013, 866.
3. Seacross Pharma (Europe) Ltd, Electronic medicines compendium (EMC), [ Revised on May 2022] [ Accessed on 26 Nov 2021], https://www.medicines.org.uk/emc/files/pil.7206.pdf
4. Sanofi-aventis US LLC, US Food and Drug Administration, [ Revised on May 2020] [ Accessed on 26 Nov 2021], https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020449s084lbl.pdf
5. Angela M Davies et al; Docetaxel in non-small cell lung cancer: a review; Expert Opinion on Pharmacotherapy; Published on April 2003; Accessed on 26/09/2022; https://pubmed.ncbi.nlm.nih.gov/12667118/
6. Katherine A Lyseng-Williamson, Caroline Fenton; Docetaxel: a review of its use in metastatic breast cancer; Drugs; Published on 2005; Accessed on 26/09/2022; https://pubmed.ncbi.nlm.nih.gov/16296875/